Meeting
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
A cell-based platform to potentiate oncolytic virus: Potential approach for cancer therapies.
Authors
Duong Nguyen
Calidi Therapeutics, San Diego, CA
Duong Nguyen, Alberto Gomez, Ashley Alamillo, Forrest Neuharth, Ivelina Minev, Thomas Herrmann, Barbara Haertl, Laura Edith Schneider, Boris Minev, Dobrin Draganov, Antonio F. Santidrian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies
Sub Track
Vaccines and Oncolytic Viruses
Citation
J Clin Oncol 38, 2020 (suppl 5; abstr 21)
Abstract #
21
Poster Bd #
C3
Abstract Disclosures
Similar Posters
First Author: Ahmed Elkhanany
Poster
2023 ASCO Annual Meeting
Immune infiltrates in metastatic uveal melanoma liver metastases and associations with clinical outcomes.
First Author: Katherine Emilie Rhoades Smith
Poster
2023 ASCO Genitourinary Cancers Symposium
Characterizing the immune phenotype of FGFR3 mutated upper tract urothelial carcinoma (UTUC) using single-cell (sc)RNA-sequencing (seq).
First Author: Andrew B Katims
Poster
2021 ASCO Annual Meeting
Microbiome signature, global methylation and immune landscape in early onset colorectal cancer.
First Author: Ning Jin